Thomas Uslar

Médico Internista y Endocrinólogo @FacMedicinaUC//MD, Endocrinology, Adrenal Team

[Thomas Uslar @ThomasUslar]

Thank you @EndoSociety @EndoSocJournals for choosing our paper for the Endocrine Society Thematic Issue on Endocrine Neoplasia and Cancer 2021 #JES #cancer https://t.co/EotlUB8hoW

[Euro J Endocrinology @EJEndo]

Real-world outcomes of finerenone in primary aldosteronism by Dipika R Mohan @ThomasUslar et al

EJE Volume 192, Issue 5, May 2025
Full article 👉 https://t.co/tzsYucX72i
ESE members free via 👉 https://t.co/CESKhK9o08

#endocrinology #finerenone #primaryaldosteronism

[Embajada de Suiza en Chile @SuizaChile]

🎓La Beca de Excelencia del Gobierno Suizo 2025-2026 ya tiene nuevos representantes chilenos
Felicitamos a Javier Sadarangani Leiva (postdoc en Historia, Universidad de Berna) y Thomas Uslar Nawrath (research fellowship, Universidad de Zúrich) por este importante logro académico.

[Irina Bancos @IrinaBancos]

Prednisone therapy (vs hydrocortisone) is associated with better quality of life in patients with #Cushing syndrome and #MACS post surgery. @MayoClinicEndo @BancosAdrenaLab @RSandooja @jasminesaini64

https://t.co/J7qoJK5SYR

[Thomas Uslar @ThomasUslar]

Progressive 11β-Hydroxysteroid Dehydrogenase Type 2 Insufficiency as Kidney Function Declines https://t.co/lQwA80u9Ia

[Therapeutic Advances in Medical Oncology @TAMedOncol]

📄Lessons from clinical trials & real-world studies in metastatic pheochromocytomas & paragangliomas: This review explores systemic therapies like radiopharmaceuticals & TKIs, and insights for future trial design

🔗 https://t.co/rJZzgbnP2m

Thanks @renebaudrand & @ThomasUslar!

[Thomas Uslar @ThomasUslar]

https://t.co/B28cCigJji

[Thomas Uslar @ThomasUslar]

Grateful to have collaborated on this important #PrimaryAldosteronism Medical Treatment Outcome Consensus. Huge thanks to @DrJunYang, Jacopo and Jessica for leading this effort! Let’s continue raising awareness of this underdiagnosed/frequent cause of #hypertension @TheLancetEndo

[Jun Yang @DrJunYang]

New consensus on assessing Primary Aldosteronism Medical treatment Outcomes (PAMO), and PAMO in 1258 patients from 28 centres around the world. Grateful to 54 co-authors for collaborating! @Hudson_Research
@EndoSocAus @SCSMonash @A5_Adrenal @TheEndoSociety
https://t.co/LIa5VmieDu

[Jun Yang @DrJunYang]

We showed an association between markers of #PrimaryAldosteronism and left ventricular mass index in young, relatively healthy, adults @RaineStudy. How early should we screen for aldosterone excess? More to research! @Hudson_Research @HypertensionAus @WeArePAOrg @EndoSocAus

[Wasita W. Parksook @WParksook]

Following SST, 100% had decreased serum Ca with ~50% developed new-onset hypocalcemia. These acute reductions in bioavailable Ca are associated with lower post-SST aldosterone. Thank you @AnandVaidya17 @JeniferBrown & the team! https://t.co/Y5DRkIC0ba

[SOCHED @Soched_cl]

El Dr. Thomas Uslar presenta "Evaluación y manejo de la hiperplasia suprarrenal congénita durante la preconcepción, embarazo y postparto", en el Curso de Enfermedades Endocrinas en la Embarazada y el Recién Nacido: Desde la preconcepción al postparto, de #SOCHED

[Irina Bancos @IrinaBancos]

Steroid Profiling and Circadian Cortisol Secretion in Patients With Mild Autonomous Cortisol Secretion: A Cross-sectional Study https://t.co/svefzrLCDp

Congratulations @BancosAdrenaLab @jasminesaini64 @MayoClinicEndo

[Jun Yang @DrJunYang]

Our meta-analysis found that in #LowReninHypertension, treatment with mineralocorticoid receptor antagonists lowered systolic BP to a greater extent compared to commonly used first-line antihypertensive agents. @Hudson_Research @EndoSocAus @HypertensionAus
https://t.co/pNnxBmrwKY

[Jun Yang @DrJunYang]

In this primary care-based study, we showed that 116 of 261 patients had #hypertension ad #LowRenin (including 47 with #PrimaryAldosteronism). Those with low renin #hypertension may benefit from specific therapy. @Hudson_Research @EndoSocAus @SCSMonash https://t.co/UByM810Ayo

[Thomas Uslar @ThomasUslar]

Progressive 11bHSD2 Insufficiency and Mineralocorticoid Receptor Activation as Kidney Function Declines -
Amazing collaboration Santiago 🇨🇱-Boston 🇺🇸 @renebaudrand @AnandVaidya17 Andrew Newman
Internacional Adrenal Meeting #IAM2024 @A5_Adrenal @TheEndoSociety #Endo2024

[Pei Chia @janoviee]

had dinner with adrenaliphias at #endo2024

[Jun Yang @DrJunYang]

My favourite time of the year (apart from school holidays)... catching up with friends from the adrenal (#PrimaryAldosteronism) world at the International Adrenal Meeting @A5_Adrenal in Boston. More fun anticipated at #ENDO2024! @Hudson_Research @TheEndoSociety

[Thomas Uslar @ThomasUslar]

SAT345 - The Prevalence of Primary Aldosteronism in Incidentally Discovered Adrenocortical Adenomas Irrespective of Blood Pressure: A Prospective Cohort Study. Excelente equipo!! 💪🏻@TheEndoSociety #ENDO2024 @FJGuardaMD @renebaudrand

[Thomas Uslar @ThomasUslar]

Clinical Update on Congenital Adrenal Hyperplasia: Recommendations from a Multidisciplinary Adrenal Program https://t.co/qjJ1hfwrO3 #mdpijcm a través de @JCM_MDPI

[Dr. Gilberto Pérez López MD PhD ┃Endocrinólogo @AndroMetabolic]

📢 ACTUALIZACIÓN EN HIPERPLASIA SUPRARRENAL CONGÉNITA #CAH @PedsEndoSociety 2022:
1️⃣ CAH-X es un subtipo de CAH causado por deleción del gen CYP21A2 + TNXB ➡️ gen quimera TNXA/TNXB
⚠️Sospecha clínica: hipermovilidad/hiperlaxitud
👁️ Tiene anomalías estructurales cardíacas ♥️